Journal of Pharmacological Sciences, 120(3), 210 - 225
There are over a hundred obesity products now in clinical development, many of them GLP-1-based, driven by strong medical need, novel drug discovery tools, and financial opportunity
The resultant pain relief is usually rapid, starting within a few days following the injection and lasting for months
Semaglutide GLP-1 is typically prescribed for approximately a year of usage, which patients can expect to lose approximately 15% of their overall weight
However, as with any injection, some individuals may experience mild side effects: Injection site reactions: Mild soreness, redness, or swelling at the injection site is the most common side effect
It would be like killing two birds with one stone